GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Other Operating Expense

PTHL (Pheton Holdings) Other Operating Expense : $-0.11 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pheton Holdings Other Operating Expense?

Pheton Holdings's Other Operating Expense for the six months ended in Dec. 2024 was $-0.09 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.11 Mil.

Pheton Holdings's quarterly Other Operating Expense increased from Dec. 2023 ($-0.04 Mil) to Jun. 2024 ($-0.02 Mil) but then declined from Jun. 2024 ($-0.02 Mil) to Dec. 2024 ($-0.09 Mil).

Pheton Holdings's annual Other Operating Expense increased from Dec. 2022 ($-0.05 Mil) to Dec. 2023 ($-0.05 Mil) but then declined from Dec. 2023 ($-0.05 Mil) to Dec. 2024 ($-0.11 Mil).

Pheton Holdings Other Operating Expense Historical Data

The historical data trend for Pheton Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pheton Holdings Other Operating Expense Chart

Pheton Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Operating Expense
-0.07 -0.05 -0.05 -0.11

Pheton Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Operating Expense Get a 7-Day Free Trial -0.03 -0.01 -0.04 -0.02 -0.09

Pheton Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pheton Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pheton Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pheton Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pheton Holdings Ltd (NAS:PTHL) » Definitions » Other Operating Expense
Comparable Companies
RTGN MGRM ICAD XTNT OWLT NSPR SRTS MYO ELUT SERA ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
Hong Jun Ying South Road, Room 306, NET Building, Chaoyang District, Beijing, CHN, 100101
Website
http://www.ftzy.com.cn
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Pheton Holdings Headlines

From GuruFocus

Pheton Holdings Ltd Announces Closing of Initial Public Offering

By Marketwired • 09-06-2024

Pheton Holdings Ltd Announces Pricing of Initial Public Offering

By Marketwired • 09-05-2024

PTHL Trading Resumes, Investors Eye Performance | PTHL Stock News

By GuruFocus News • 05-27-2025

PTHL Trading Halted Due to Volatility Pause | PTHL Stock News

By GuruFocus News • 05-27-2025